Inventor · disambiguated record
Karin Sandager Nielsen
Also filed as: NIELSEN KARIN · NIELSEN KARIN SANDAGER
11 granted patents·13 pending applications·39 citations·filing 2002–2022
87Inventor score
Top patents by PatentIndex Score
24 records- 0193US9975886B1Potassium channel modulatorsCADENT THERAPEUTICS INC·Filed 2018·Granted May 22, 2018·9 cites·2 claims
- 0290US7960561B22-(phenylamino) benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channelsNEUROSEARCH AS·Filed 2006·Granted Jun 14, 2011·18 cites·6 claims
- 0386US10351553B2Potassium channel modulatorsCADENT THERAPEUTICS INC·Filed 2018·Granted Jul 16, 2019·3 cites·6 claims
- 0480US10717728B2Potassium channel modulatorsCADENT THERAPEUTICS INC·Filed 2019·Granted Jul 21, 2020·1 cites·7 claims
- 0575US7737167B22-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channelsNEUROSEARCH AS·Filed 2005·Granted Jun 15, 2010·2 cites·11 claims
- 0673US7842817B22-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channelsNEUROSEARCH AS·Filed 2006·Granted Nov 30, 2010·1 cites·6 claims
- 0768US9133184B2Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitorsANIONA APS·Filed 2014·Granted Sep 15, 2015·2 cites·3 claims
- 0867US2021380571A1Potassium channel modulatorsCADENT THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0966US8697721B2Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitorsPETERS DAN·Filed 2010·Granted Apr 15, 2014·1 cites·6 claims
- 1066US7160899B2Adenosine A2A receptor antangonists combined with neurotrophic activity compounds in the treatment of Parkinson's diseaseNEUROSEARCH AS·Filed 2002·Granted Jan 9, 2007·2 cites·6 claims
- 1158US2022143014A1Selective Agonist Of Alpha6 Containing nAChRsGLORIANA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1258US2018311238A1Selective Agonist Of a6 Containing nAChRsSANIONA AS·Filed 2018·Application pending·0 cites
- 1356US2024197733A1A gaba receptor modulator for use in the treatment of painSANIONA AS·Filed 2022·Application pending·0 cites
- 1452US11396510B2GABAA receptor ligandSANIONA AS·Filed 2019·Granted Jul 26, 2022·0 cites·11 claims
- 1548US2011085978A1Novel quinolinylamide derivatives useful as modulators of dopamine and serotonin receptorsNEUROSEARCH AS·Filed 2009·Application pending·0 cites
- 1647US2011059019A1Novel aryl piperazine derivatives useful as modulators of dopamine and serotonin receptorsNEUROSEARCH AS·Filed 2009·Application pending·0 cites
- 1745US2005118151A1Proteins in diabetes proteome anlysisUNIV SYDDANSK·Filed 2004·Application pending·0 cites
- 1842US2013040985A1Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitorsNEUROSEARCH AS·Filed 2011·Application pending·0 cites
- 1942US2011034527A1Novel 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channelsSOERENSEN ULRIK SVANE·Filed 2010·Application pending·0 cites
- 2041US2010280087A1Novel 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channelsSOERENSEN ULRIK SVANE·Filed 2010·Application pending·0 cites
- 2140US2018207138A1Methods for the treatment of tremors by positive modulation of sk channelsCADENT THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2239US2010087445A1Aryl piperazine derivatives useful for the treatment of neuropsychiatry disordersUNIV SIENA·Filed 2007·Application pending·0 cites
- 2336US2009238761A1Novel Aryl Piperazine Derivatives With Medical UtilityUNIV SIENA·Filed 2006·Application pending·0 cites
- 2435US7199118B2Benzothiazine derivatives, their preparation and useNEUROSEARCH AS·Filed 2002·Granted Apr 3, 2007·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Karin Sandager Nielsen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →